Four-Octyl Itaconate Attenuates UVB-Induced Melanocytes and Keratinocytes Apoptosis by Nrf2 Activation-Dependent ROS

Yongyi Xie1, Zile Chen1, Zhouwei Wu1

  • 1Department of Dermatology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China.

Insights

4-octyl itaconate (4-OI) protects skin cells from UVB damage by reducing reactive oxygen species (ROS) and activating the Nrf2 pathway. This compound shows potential for treating oxidative stress-related skin disorders like vitiligo.

Area of Science:

  • Dermatology
  • Cell Biology
  • Oxidative Stress Research

Background:

  • Vitiligo is an acquired skin depigmentation disease where excessive reactive oxygen species (ROS) cause melanocyte destruction.
  • The interaction between melanocytes and keratinocytes is crucial, suggesting treatments protecting both cell types may be beneficial.

Purpose of the Study:

  • To investigate the protective effects of 4-octyl itaconate (4-OI) against ultraviolet B (UVB)-induced apoptosis in HaCaT and PIG1 cells.
  • To elucidate the underlying mechanisms, including ROS reduction and the role of the Nrf2 pathway.

Main Methods:

  • HaCaT and PIG1 cells were pretreated with 4-OI before UVB exposure.
  • ROS levels and apoptosis were measured using fluorescence microscopy and flow cytometry.
  • Protein and mRNA expression, and nuclear translocation were analyzed via confocal microscopy, western blotting, and qRT-PCR.
  • In vivo studies utilized the Institute of Cancer Research (ICR) mouse model.

Main Results:

  • UVB exposure induced apoptosis in HaCaT and PIG1 cells, which was reversed by inhibiting ROS production.
  • 4-OI significantly reduced UVB-induced apoptosis in a concentration-dependent manner by decreasing ROS levels.
  • 4-OI promoted nuclear translocation and activation of nuclear factor erythroid 2-related factor 2 (Nrf2).
  • Nrf2 silencing counteracted the protective effects of 4-OI.
  • In vivo, 4-OI treatment reduced UVB-induced skin damage in mice.

Conclusions:

  • 4-octyl itaconate (4-OI) protects melanocytes and keratinocytes from UVB-induced apoptosis.
  • The protective mechanism involves Nrf2 activation-dependent inhibition of ROS.
  • 4-OI demonstrates potential as a therapeutic agent for skin disorders linked to oxidative stress, such as vitiligo.